Home » Topics » Regulatory » Patents

Patents
RSS

New NMDA antagonists described by Zeneca

Nov. 26, 1996

Asta Medica reports new PDE IV and PDE V inhibitors

Nov. 26, 1996

Cyclic hexapeptide antifungal agents claimed by Lilly

Nov. 26, 1996

New antihypertensive agent from Calpis Food Industry

Nov. 26, 1996

Sandoz claims MAbs against Lewis group antigens for therapeutic use

Nov. 25, 1996

More antiobesity proteins reported by Lilly

Nov. 25, 1996

Maxi-K channel modulators from Bristol-Myers Squibb

Nov. 25, 1996

Merck & Co. cephalosporins active against MRSA, MRCNS

Nov. 25, 1996

Lilly claims structurally novel NK1 antagonists

Nov. 25, 1996

Mercian discloses novel mitomycin

Nov. 22, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...